Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2003
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003US20030148312 Measuring the expression level of MAL gene; atopic dermatitis and bronchial asthma
08/07/2003US20030148099 Microcapsules having high carotenoid content
08/07/2003US20030147942 Pharmaceutical gel composition
08/07/2003US20030147937 Di-myo-inositol phosphate, cyclic 2,3 diphosphoglycerate, 1,1-di- glycerol phosphate, mannosylglycerate, mannosyl glyceramide and/or di-mannosyl-di-inositol phosphate; protecting organisms, organs, tissues, cells from oxidation
08/07/2003US20030147928 Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect
08/07/2003US20030147889 Administering type 1-interferon antibody, for inhibition of prevention of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis and psoriasis
08/07/2003US20030147879 Method of improving wound healing
08/07/2003US20030147876 Combination of a growth factor and a protease enzyme
08/07/2003US20030147861 Compounds and methods for the modulation of immune responses
08/07/2003US20030147831 Hair follicle growth
08/07/2003US20030147824 Hair cosmetic composition
08/07/2003US20030147823 Using a cyclopentane compound
08/07/2003CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003CA2475003A1 Double-stranded oligonucleotides
08/07/2003CA2474910A1 Oligonucleotide compositions with enhanced efficiency
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474852A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003CA2474788A1 Compositions and methods for modulating connexin hemichannels
08/07/2003CA2474723A1 Bioactive keratin peptides
08/07/2003CA2474719A1 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/07/2003CA2474717A1 Cosmetic or dermatological use of vitamin a or the esters thereof in combination with a partly methylated beta-cyclodextrin
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473457A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003CA2473249A1 New corticosteroids
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003CA2473128A1 Genetic polymorphisms in the preprotachykinin gene
08/07/2003CA2443023A1 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/06/2003EP1333034A1 Use of angiotensin II analogs in tissue repair
08/06/2003EP1333022A2 Compounds containing derivatives of cyclopentane and their use to stimulate skin peeling
08/06/2003EP1333021A2 Compositions containing derivatives of jasmonic acid and their use for stimulating skin peeling
08/06/2003EP1332772A2 Anti-dandruff and anti-itch compositions containing a cooling sensate material and a cooling sensate enhancer
08/06/2003EP1332758A1 Dermatological compositions comprising a corticosteroid and zinc pyrithione
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332218A1 Differentiation-inducing substances
08/06/2003EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
08/06/2003EP1332147A1 Thieno[2,3-c isoquinolines for use as inhibitors of parp
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332128A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331934A1 Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causes
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1331927A1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
08/06/2003EP1331925A2 Use of an association of at least a carotenoid and of at least an isoflavonoid for treating cutaneous symptoms of ageing
08/06/2003EP1331924A2 Use of carotenoids for treating ageing symptoms
08/06/2003EP1331923A2 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1105051A4 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
08/06/2003EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds
08/06/2003EP0906086B1 Skin wash composition
08/06/2003EP0824353A4 Methods to inhibit acute radiation-induced skin damage
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434810A Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434716A Anti-adhesive agent in relation to pathogenic flora of skin
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434698A Hair growth stimulant compositions
08/06/2003CN1434697A Hair growth stimulant compositions with sustained action
08/06/2003CN1433815A Biological wound protection adhesive plaster
08/06/2003CN1433807A Compound psorolea tincture for treating leukoderma
08/06/2003CN1433800A Method for producing health care capsule for beautifying and delaying senility
08/06/2003CN1433793A Ointment for treating chilblain
08/06/2003CN1433785A Formula of adhesive plaster for treating painful swelling
08/06/2003CN1433781A Wanli ointment
08/06/2003CN1433777A Cerium carried (Ôàó) rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof
08/06/2003CN1433776A Process for preparing colloidal silver solution
08/06/2003CN1433753A Cosmetics for curing acne
08/06/2003CN1433747A Natural medicinal hair-growing agent
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
08/06/2003CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
08/06/2003CN1116886C Process for preparing Chinese-medicinal pills containing borneol
08/06/2003CN1116880C Use of puffer liver oil in preparing food for curing poisonous drug dependence
08/06/2003CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness
08/06/2003CN1116865C Use of crosslinked cation polymer in skin cosmetics and skin disease preparations
08/06/2003CN1116864C Health-care shampoo and its preparing process
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
1 ... 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 ... 1065